Diet, micronutrients, and the prostate gland

Nutrition Reviews

Volumn 57, Issue 4, 1999, Pages 95-103

  Thomas, John A ^a,b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; LYCOPENE; PHYTOESTROGEN; PHYTOSTEROL; SELENIUM; TRACE ELEMENT; ZINC;

CANCER RISK; DIETARY INTAKE; FAT INTAKE; HUMAN; MALE; PROSTATE CANCER; PROSTATE HYPERTROPHY; REVIEW; UNITED STATES;

EID: 0032966546     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-4887.1999.tb06932.x     Document Type: Review

References (101)

1. Blumberg J. Nutritional needs of seniors. J Am Coll Nutr 1997;16:517-23
2. Tucker K. Micronutrient status and aging. Nutr Rev 1995;53:9-15
3. Wood RJ, Suter MS, Russell RM. Mineral requirements of elderly people. Am J Clin Nutr 1995;62: 493-505
4. Willett WC. Specific fatty acids and risks of breast and prostate cancer: dietary intake. Am J Clin Nutr 1997;66:1557-63
5. Giovannucci E. Epidemiologic characteristics of prostate cancer. Cancer 1995;75:1766-77
6. Haenszel W, Kurihara M. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 1968;40:43-68
7. Staszewski W, Haenszel W. Cancer mortality among the Polish-born in the United States. J Natl Cancer Inst 1965;35:291-7
8. Shibata A, Ma J, Whittemore AS. Prostate cancer incidence and mortality in the United States and the United Kingdom. J Natl Cancer Inst 1998;90: 1230-1
9. Jensen OM, Esteve J, Moller H, Renard H. Cancer in the European community and its member states. Eur J Cancer 1990;26:1167-256
10. Muir CS, Nectoux J, Staszewski J. The epidemiology of prostatic cancer. Acta Oncol 1991;30:133-40
11. Kemp ED. Prostate cancer: finding and managing it. Postgrad Med 1992;92:67-84
12. Ilic M, Vlajinac H, Marinkovic J. Case-control study of risk factors for prostate cancer. Br J Cancer 1996;74:1682-6
13. van der Gulden JWJ. Metal workers and repairmen at risk for prostate cancer: a review. Prostate 1997;30:107-16
14. Carter BS, Ballantine-Carter H, Issacs JT. Epidemiologic evidence regarding predisposing factors to prostate cancer. Prostate 1990;16:187-97
15. Kolonel LN. Nutrition and prostate cancer. Cancer Causes Control 1996;7:83-94
16. Yip I, Aronson W, Heber D. Nutritional approaches to the prevention of prostate cancer progression. In: Heber D, Kritchevsky D, eds. Dietary fats, lipids, hormones, and tumorigenesis. New York: Plenum Press, 1996
17. Gann PH, Henekens CH, Sacks FM, et al. Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst 1994;86:281-6
18. Rose DP, Connolly JM. Dietary fat, fatty acids, and prostate cancer. Lipids 1992;27:798-803
19. West DW, Slattery ML, Robison LM, et al. Adult dietary intake and prostate cancer risk in Utah: a case-control study with special emphasis on aggressive tumors. Cancer Causes Control 1991; 2:85-94
20. Giovannucci E, Rimm EB, Colditz GA, et al. A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst 1993;85:1571-9
21. Zhou JR, Blackburn GL. Bridging animal and human studies: what are the missing segments in dietary fat and prostate cancer? Am J Clin Nutr 1997;66:1572-80
22. Dwyer JT. Human studies on the effects of fatty acids on cancer: summary, gaps, and future research. Am J Clin Nutr 1997;66:1581-6
23. Karmali RA. Eicosanoids in neoplasia. Prev Med 1987;16:493-502
24. Rose DP, Connolly JM. Effects of fatty acids and eicosanoid synthesis inhibitors on the growth of two human prostate cancer cell lines. Prostate 1991;18:243-54
25. Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965;58:295-300
26. Glynn JR. A question of attribution. Lancet 1993;342:530-2
27. Giles G, Ireland P. Diet, nutrition, and prostate cancer. Int J Cancer 1997;10:13-7
28. Howell MA. Factor analysis of international cancer mortality data and per capita food consumption. Br J Cancer 1974;29:328-36
29. Blair A, Fraumeni JF Jr. Geographic patterns of prostate cancer in the United States. J Natl Cancer Inst 1978;61:379-84
30. Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 1975;15:617-31
31. Rosenberg L, Palmer JR, Zauber AG, et al. Vasectomy and the risk of prostate cancer. Am J Epidemiol 1990;132:1051-5
32. La Vecchia C. Cancers associated with high-fat diets. Natl Cancer Inst Monographs 1992;12:79-85
33. Wynder EL, Rose DP, Cohen LA. Nutrition and prostate cancer: a proposal for dietary intervention. Nutr Cancer 1994;22:1-10
34. Heshmat MY, Kaul L, Kovi J, et al. Nutrition and prostate cancer: a case-control study. Prostate 1985;6:7-17
35. Kolonel LN, Yoshizawa CN, Hankin JH. Diet and prostatic cancer: a case-control study in Hawaii. Am J Epidemiol 1988;127:999-1012
36. Ross RK, Shimizu H, Paganini-Hill A, et al. Case-control studies of prostate cancer in blacks and white in southern California. J Natl Cancer Inst 1987;78:869-74
37. Andersson SO, Wolk A, Bergström R, et al. Energy, nutrient intake, and prostate cancer risk: a population-based case-control study in Sweden. Int J Cancer 1996;68:716-22
38. Ghadirian P, Lacroix A, Maisonneuve P, et al. Nutritional factors and prostate cancer: a case-control study of French Canadians in Montreal, Canada. Cancer Causes Control 1996;7:428-36
39. Graham S, Haughey B, Marshall J, et al. Diet in the epidemiology of carcinoma of the prostate gland. J Natl Cancer Inst 1983;70:687-92
40. Kaul L, Heshmat MY, Kovi J, et al. The role of diet in prostate cancer. Nutr Cancer 1987;9:123-8
41. Mettlin C, Selenskas S, Natarajan N, Huben R. Beta-carotene and animal fats and their relationship to prostate cancer risk: a case-control study. Cancer 1989;64:605-12
42. Meyer F, Bairati I, Fradet Y, Moore L. Dietary energy and nutrients in relation to preclinical prostate cancer. Nutr Cancer 1997;29:120-6
43. Mishina T, Watanabe H, Araki H, et al. Epidemiological study of prostatic cancer by matched-pair analysis. Prostate 1985;6:423-36
44. Talamini R, La Vecchia C, Decarli A, et al. Nutrition, social factors and prostatic cancer in a northern Italian population. Br J Cancer 1986;53:817-21
45. Veierød MB, Laake P, Thelle DS. Dietary fat intake and risk of prostate cancer: a prospective study of 25,708 Norwegian men. Int J Cancer 1997;73:634-8
46. Vlajinac HD, Marinkovic JM, Ilic MD, Kocev NI. Diet and prostate cancer: a case-control study. Eur J Cancer 1997;33:101-7
47. Walker ARP, Walker BF, Tsotetsi NG, et al. Case-control study of prostate cancer in black patients in Soweto, South Africa. Br J Cancer 1992;65:438-41
48. Whittemore AS, Kolonel LN, Wu AH, et al. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst 1995;87: 652-61
49. Rotkin ID. Studies in the epidemiology of prostatic cancer: expanded sampling. Cancer Treat Rep 1977;61:173-80
50. Byers T, Bieseker K. Issues in the design and interpretation of studies of fatty acids and cancer in humans. Am J Clin Nutr 1997;66:1541-7
51. Coward L, Barnes NC, Setchell KDR, Barnes S. Genistein, diadzein and their ß-glycoside conjugates: antitumor isoflavones in soybean foods from American and Asian diets. J Agric Food Chem 1993;41:1961-7
52. Messina MJ, Persky V, Setchell KD, Barnes S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 1994;1:113-31
53. Messina M, Barnes S. The role of soy products in reducing risk of cancer. J Natl Cancer Inst 1991;83: 541-6
54. Schuman LM, Mandel JS, Radke A, et al. Some selected features of the epidemiology of prostatic cancer: Minneapolis-St. Paul, Minnesota case-control study, 1976-1979. In: Magnus K, ed. Trends in cancer incidence. Washington, DC: Hemisphere, 1982
55. Peterson G, Barnes S. Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor autophosphorylation. Prostate 1993;22:335-45
56. Kuiper GGJM, Lemmen JG, Carlsson B, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor B. Endocrin 1998;139:4252-63
57. Negri E, La Vecchia C, Franceschi S, et al. Vegetable and fruit consumption and cancer risk. Int J Cancer 1991;48:350-4
58. Le Marchand L, Kolonel LN, Wilkens LR, et al. Animal fat consumption and prostate cancer: a prospective study in Hawaii. Epidemiology 1994;5: 276-82
59. Hirayama T. A large-scale cohort study on cancer risks by diet, with special reference to the risk reducing effect of green-yellow vegetable consumption. In: Hayashi Y, ed. Diet, nutrition and cancer. Tokyo: Japan Scientific Society Press, 1986
60. Hsing AW, McLaughlin JK, Schuman LM, et al. Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood cohort study. Cancer Res 1990;50:6836-40
61. Heinonen OP, Albanes D, Virtamo J, et al. Prostate cancer and supplementation with α-tocopherol and β-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 1998;90:440-6
62. Hartman TJ, Albanes D, Rautalahti M, et al. Physical activity and prostate cancer in the alpha-tocopherol-beta-carotene (ATBC) cancer prevention study (Finland). Cancer Causes Control 1998;9: 11-8
63. Marchand LL, Hankin JH, Kolonel LN, Wilkens LR. Vegetable and fruit consumption in relation to prostate cancer risk in Hawaii: a reevaluation of the effect of dietary beta-carotene. Am J Epidemiol 1991;133:215-9
64. Krinsky NI. Overview of lycopene, carotenoids, and disease prevention. Proc Soc Exp Biol Med 1998;218:95-7
65. Clinton SK. Lycopene: chemistry, biology, and implications for human health and disease. Nutr Rev 1998;56:35-51
66. Giovannucci EL, Ascherio A, Rimm EB, et al. Intake of carotenoids and retinol in relationship to risk of prostate cancer. J Natl Cancer Inst 1995;87:1767-76
67. Franceschi S, Bidoli E, La Vecchia C, et al. Tomatoes and risk of digestive disease cancers. Int J Cancer 1994;59:181-4
68. Giovanucci E. Tomatoes, tomato-based products, lycopene, and cancer: a review of the epidemiologic literature. J Natl Cancer Inst 1999;91:317-31
69. Clinton SK, Emenhiser C, Schwarte SJ, et al. Cistrans lycopene isomers, carotenoids, and retinol in the human prostate. Cancer Epidemiol Biomarkers Prev 1996;5:823-33
70. Zhao A, Khachik F, Richie JP, Cohen LA. Lycopene uptake and tissue disposition in male and female rats. Proc Soc Exp Biol Med 1998;218:109-14
71. Mills PK, Beeson WL, Phillips RL, Fraser GE. Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer 1989;64:598-604
72. Hsing AW, Comstock GW, Abbey H, Polk BR. Serologic precursors of cancer: retinol, carotenoids, and tocopherol and risk of prostate cancer. J Natl Cancer Inst 1990;82:941-6
73. Nomura AMY Stemmermann GN, Lee J, Craft NE. Serum micronutrients and prostate cancer in Japanese Americans in Hawaii. Cancer Epidemiol Biomarkers Prev 1997;6:487-92
74. Aboseif SR, Dahiya R, Narayan P, Cunha GR. Effect of retinoic acid on prostatic development. Prostate 1997;31:161-7
75. Schwarz K, Bieri JG, Briggs GM, Scott ML. Prevention of exudative diathesis in chicks by factor 3 and selenium. Proc Soc Exp Biol Med 1957;95:621-5
76. Combs GF Jr, Gray WP. Chemopreventive agents: selenium. Pharmacol Ther 1998;79:179-92
77. Hunter DJ, Morris JS, Stampfer MJ, et al. A prospective study of selenium status and breast cancer risk. JAMA 1990;264:1128-31
78. van den Brandt PA, Goldbohm RA, van't Veer P, et al. A prospective cohort study on selenium levels and risk of gastrointestinal cancer. J Natl Cancer Inst 1993;85:224-9
79. Willett WC, Polk BF, Morris JS, et al. Prediagnostic serum selenium and risk of cancer. Lancet 1983;2:130-4
80. Yoshizawa K, Willett WC, Morris SJ, et al. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst 1998;90:1219-24
81. Taylor PR, Albanes D. Selenium, vitamin E, and prostate cancer: ready for prime time? J Natl Cancer Inst 1998;90:1184-5
82. Clark LC, Combs GF Jr, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: a randomized controlled trial. JAMA 1996;276:1957-63
83. The Alpha-tocopherol, Beta-carotene Cancer Prevention Study Group. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330.1029-35
84. Zaichick W, Sviridova TV, Zaichick SV. Zinc in the human prostate gland: normal, hyperplastic, and cancerous. Int J Urol Nephrol 1997;29:565-74
85. Brys M, Nawrocka AD, Miekos E, et al. Zinc and cadmium analysis in human prostate neoplasms. Biol Trace Elem Res 1997;59:145-52
86. Zaichick VY, Sviridova W, Zaichick SV. Zinc concentration in human prostatic fluid: normal, chronic prostatitis, adenoma and cancer. Int J Urol Nephrol 1996;28:687-94
87. Costello LC, Franklin RB. Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer. Prostate 1998;35.285-96
88. Hayes RB, Brown LM, Schoenberg JB, et al. Alcohol use and prostate cancer risk in U.S. blacks and whites. Am J Epidemiol 1996;143:692-7
89. Lumey LH, Pittman B, Wynder EL Alcohol use and prostate cancer in U.S. whites: no association in a confirmatory study. Prostate 1998;36:250-5
90. Giovannucci E, Rimm EB, Wolk A, et al. Calcium and fructose intake in relation to risk of prostate cancer. Cancer Res 1998;58:442-7
91. Giovannucci E, Rimm EB, Stampfer MJ, et al. Diabetes mellitus and risk of prostate cancer (United States). Cancer Causes Control 1998;9:3-9
92. Henderson BE, Bogdanoff E, Gerkins VR, et al. Evaluation of cancer risk factors in a retirement community. Cancer Res 1974;34:1045-8
93. Thompson MM, Garland C, Barrett-Connor E, et al. Heart disease risk factors, diabetes, and prostatic cancer in an adult community. Am J Epidemiol 1989;129:511-7
94. Adami HO, McLaughlin J, Ekbom A, et al. Cancer risk in patients with diabetes mellitus. Cancer Causes Control 1991;2:307-14
95. Barry M, Roehrborn C. Management of benign prostatic hyperplasia. Annu Rev Med 1997;48:177-89
96. Shimazu H, Ross RK, Bernstein L, et al. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 1991;63:963-6
97. Berges RR, Windeler J, Trampisch HJ, Senge T. Randomised, placebo-controlled, double-blind clinical trial of β-sitosterol in patients with benign prostatic hyperplasia. Lancet 1995;345:1529-32
98. Ohno Y, Yoshida O, Oishi K, et al. Dietary beta-carotene and cancer of the prostate: a case-control study in Kyoto, Japan. Cancer Res 1988;48:1331-6
99. De Smet P. The role of plant-derived drugs and herbal medicines in healthcare. Drugs 1997;54: 801-40
100. von Holtz RL, Fink CS, Awad AB. Beta-sitosterol activates the sphingomyelin cycle and induces apoptosis in LNCaP human prostate cancer cells. Nutr Cancer 1998;32:8-12
101. Geller J, Sionit L, Partido C, et al. Genistein inhibits the growth of human-patient BPH and prostate cancer in histoculture. Prostate 1998;34:75-9